COVID-19 Impact on Global Pharmaceuticals for Women's Health Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C15E865162ACEN
QYResearch

Abstracts

This report focuses on the global Pharmaceuticals for Women's Health status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceuticals for Women's Health development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Allergan
• Lilly
• Pfizer
• Bayer
• AbbVie
• Amgen
• Johnson?Johnson

Market segment by Type, the product can be split into

• Granules
• Pills
• Powder
• Tincture
• Tablets
• Capsule
• Other

Market segment by Application, split into

• Postmenopausal Osteoporosis
• Endometriosis
• Polycystic Ovarian Syndrome
• Pregnancy Disorders
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pharmaceuticals for Women's Health status, future forecast, growth opportunity, key market and key players.
• To present the Pharmaceuticals for Women's Health development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceuticals for Women's Health are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceuticals for Women's Health Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Granules
  1.4.3 Pills
  1.4.4 Powder
  1.4.5 Tincture
  1.4.6 Tablets
  1.4.7 Capsule
  1.4.8 Other
1.5 Market by Application
  1.5.1 Global Pharmaceuticals for Women's Health Market Share by Application: 2020 VS 2026
  1.5.2 Postmenopausal Osteoporosis
  1.5.3 Endometriosis
  1.5.4 Polycystic Ovarian Syndrome
  1.5.5 Pregnancy Disorders
  1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceuticals for Women's Health Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pharmaceuticals for Women's Health Industry
    1.6.1.1 Pharmaceuticals for Women's Health Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pharmaceuticals for Women's Health Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pharmaceuticals for Women's Health Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmaceuticals for Women's Health Market Perspective (2015-2026)
2.2 Pharmaceuticals for Women's Health Growth Trends by Regions
  2.2.1 Pharmaceuticals for Women's Health Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmaceuticals for Women's Health Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmaceuticals for Women's Health Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmaceuticals for Women's Health Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmaceuticals for Women's Health Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmaceuticals for Women's Health Players by Market Size
  3.1.1 Global Top Pharmaceuticals for Women's Health Players by Revenue (2015-2020)
  3.1.2 Global Pharmaceuticals for Women's Health Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmaceuticals for Women's Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceuticals for Women's Health Market Concentration Ratio
  3.2.1 Global Pharmaceuticals for Women's Health Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmaceuticals for Women's Health Revenue in 2019
3.3 Pharmaceuticals for Women's Health Key Players Head office and Area Served
3.4 Key Players Pharmaceuticals for Women's Health Product Solution and Service
3.5 Date of Enter into Pharmaceuticals for Women's Health Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmaceuticals for Women's Health Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceuticals for Women's Health Forecasted Market Size by Type (2021-2026)

5 PHARMACEUTICALS FOR WOMEN'S HEALTH BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmaceuticals for Women's Health Market Size by Application (2015-2020)
5.2 Global Pharmaceuticals for Women's Health Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmaceuticals for Women's Health Market Size (2015-2020)
6.2 Pharmaceuticals for Women's Health Key Players in North America (2019-2020)
6.3 North America Pharmaceuticals for Women's Health Market Size by Type (2015-2020)
6.4 North America Pharmaceuticals for Women's Health Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmaceuticals for Women's Health Market Size (2015-2020)
7.2 Pharmaceuticals for Women's Health Key Players in Europe (2019-2020)
7.3 Europe Pharmaceuticals for Women's Health Market Size by Type (2015-2020)
7.4 Europe Pharmaceuticals for Women's Health Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmaceuticals for Women's Health Market Size (2015-2020)
8.2 Pharmaceuticals for Women's Health Key Players in China (2019-2020)
8.3 China Pharmaceuticals for Women's Health Market Size by Type (2015-2020)
8.4 China Pharmaceuticals for Women's Health Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmaceuticals for Women's Health Market Size (2015-2020)
9.2 Pharmaceuticals for Women's Health Key Players in Japan (2019-2020)
9.3 Japan Pharmaceuticals for Women's Health Market Size by Type (2015-2020)
9.4 Japan Pharmaceuticals for Women's Health Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmaceuticals for Women's Health Market Size (2015-2020)
10.2 Pharmaceuticals for Women's Health Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceuticals for Women's Health Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceuticals for Women's Health Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmaceuticals for Women's Health Market Size (2015-2020)
11.2 Pharmaceuticals for Women's Health Key Players in India (2019-2020)
11.3 India Pharmaceuticals for Women's Health Market Size by Type (2015-2020)
11.4 India Pharmaceuticals for Women's Health Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmaceuticals for Women's Health Market Size (2015-2020)
12.2 Pharmaceuticals for Women's Health Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceuticals for Women's Health Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceuticals for Women's Health Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview and Its Total Revenue
  13.1.3 Allergan Pharmaceuticals for Women's Health Introduction
  13.1.4 Allergan Revenue in Pharmaceuticals for Women's Health Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Lilly
  13.2.1 Lilly Company Details
  13.2.2 Lilly Business Overview and Its Total Revenue
  13.2.3 Lilly Pharmaceuticals for Women's Health Introduction
  13.2.4 Lilly Revenue in Pharmaceuticals for Women's Health Business (2015-2020)
  13.2.5 Lilly Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Pharmaceuticals for Women's Health Introduction
  13.3.4 Pfizer Revenue in Pharmaceuticals for Women's Health Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Bayer
  13.4.1 Bayer Company Details
  13.4.2 Bayer Business Overview and Its Total Revenue
  13.4.3 Bayer Pharmaceuticals for Women's Health Introduction
  13.4.4 Bayer Revenue in Pharmaceuticals for Women's Health Business (2015-2020)
  13.4.5 Bayer Recent Development
13.5 AbbVie
  13.5.1 AbbVie Company Details
  13.5.2 AbbVie Business Overview and Its Total Revenue
  13.5.3 AbbVie Pharmaceuticals for Women's Health Introduction
  13.5.4 AbbVie Revenue in Pharmaceuticals for Women's Health Business (2015-2020)
  13.5.5 AbbVie Recent Development
13.6 Amgen
  13.6.1 Amgen Company Details
  13.6.2 Amgen Business Overview and Its Total Revenue
  13.6.3 Amgen Pharmaceuticals for Women's Health Introduction
  13.6.4 Amgen Revenue in Pharmaceuticals for Women's Health Business (2015-2020)
  13.6.5 Amgen Recent Development
13.7 Johnson?Johnson
  13.7.1 Johnson?Johnson Company Details
  13.7.2 Johnson?Johnson Business Overview and Its Total Revenue
  13.7.3 Johnson?Johnson Pharmaceuticals for Women's Health Introduction
  13.7.4 Johnson?Johnson Revenue in Pharmaceuticals for Women's Health Business (2015-2020)
  13.7.5 Johnson?Johnson Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pharmaceuticals for Women's Health Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceuticals for Women's Health Revenue
Table 3. Ranking of Global Top Pharmaceuticals for Women's Health Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Granules
Table 6. Key Players of Pills
Table 7. Key Players of Powder
Table 8. Key Players of Tincture
Table 9. Key Players of Tablets
Table 10. Key Players of Capsule
Table 11. Key Players of Other
Table 12. COVID-19 Impact Global Market: (Four Pharmaceuticals for Women's Health Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Pharmaceuticals for Women's Health Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Pharmaceuticals for Women's Health Players to Combat Covid-19 Impact
Table 17. Global Pharmaceuticals for Women's Health Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Pharmaceuticals for Women's Health Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Pharmaceuticals for Women's Health Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Pharmaceuticals for Women's Health Market Share by Regions (2015-2020)
Table 21. Global Pharmaceuticals for Women's Health Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Pharmaceuticals for Women's Health Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Pharmaceuticals for Women's Health Market Growth Strategy
Table 27. Main Points Interviewed from Key Pharmaceuticals for Women's Health Players
Table 28. Global Pharmaceuticals for Women's Health Revenue by Players (2015-2020) (Million US$)
Table 29. Global Pharmaceuticals for Women's Health Market Share by Players (2015-2020)
Table 30. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals for Women's Health as of 2019)
Table 31. Global Pharmaceuticals for Women's Health by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Pharmaceuticals for Women's Health Product Solution and Service
Table 34. Date of Enter into Pharmaceuticals for Women's Health Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 37. Global Pharmaceuticals for Women's Health Market Size Share by Type (2015-2020)
Table 38. Global Pharmaceuticals for Women's Health Revenue Market Share by Type (2021-2026)
Table 39. Global Pharmaceuticals for Women's Health Market Size Share by Application (2015-2020)
Table 40. Global Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 41. Global Pharmaceuticals for Women's Health Market Size Share by Application (2021-2026)
Table 42. North America Key Players Pharmaceuticals for Women's Health Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Pharmaceuticals for Women's Health Market Share (2019-2020)
Table 44. North America Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 45. North America Pharmaceuticals for Women's Health Market Share by Type (2015-2020)
Table 46. North America Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 47. North America Pharmaceuticals for Women's Health Market Share by Application (2015-2020)
Table 48. Europe Key Players Pharmaceuticals for Women's Health Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Pharmaceuticals for Women's Health Market Share (2019-2020)
Table 50. Europe Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Pharmaceuticals for Women's Health Market Share by Type (2015-2020)
Table 52. Europe Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Pharmaceuticals for Women's Health Market Share by Application (2015-2020)
Table 54. China Key Players Pharmaceuticals for Women's Health Revenue (2019-2020) (Million US$)
Table 55. China Key Players Pharmaceuticals for Women's Health Market Share (2019-2020)
Table 56. China Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 57. China Pharmaceuticals for Women's Health Market Share by Type (2015-2020)
Table 58. China Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 59. China Pharmaceuticals for Women's Health Market Share by Application (2015-2020)
Table 60. Japan Key Players Pharmaceuticals for Women's Health Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Pharmaceuticals for Women's Health Market Share (2019-2020)
Table 62. Japan Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Pharmaceuticals for Women's Health Market Share by Type (2015-2020)
Table 64. Japan Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Pharmaceuticals for Women's Health Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Pharmaceuticals for Women's Health Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Pharmaceuticals for Women's Health Market Share (2019-2020)
Table 68. Southeast Asia Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Pharmaceuticals for Women's Health Market Share by Type (2015-2020)
Table 70. Southeast Asia Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Pharmaceuticals for Women's Health Market Share by Application (2015-2020)
Table 72. India Key Players Pharmaceuticals for Women's Health Revenue (2019-2020) (Million US$)
Table 73. India Key Players Pharmaceuticals for Women's Health Market Share (2019-2020)
Table 74. India Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 75. India Pharmaceuticals for Women's Health Market Share by Type (2015-2020)
Table 76. India Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 77. India Pharmaceuticals for Women's Health Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Pharmaceuticals for Women's Health Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Pharmaceuticals for Women's Health Market Share (2019-2020)
Table 80. Central & South America Pharmaceuticals for Women's Health Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Pharmaceuticals for Women's Health Market Share by Type (2015-2020)
Table 82. Central & South America Pharmaceuticals for Women's Health Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Pharmaceuticals for Women's Health Market Share by Application (2015-2020)
Table 84. Allergan Company Details
Table 85. Allergan Business Overview
Table 86. Allergan Product
Table 87. Allergan Revenue in Pharmaceuticals for Women's Health Business (2015-2020) (Million US$)
Table 88. Allergan Recent Development
Table 89. Lilly Company Details
Table 90. Lilly Business Overview
Table 91. Lilly Product
Table 92. Lilly Revenue in Pharmaceuticals for Women's Health Business (2015-2020) (Million US$)
Table 93. Lilly Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Pharmaceuticals for Women's Health Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Pharmaceuticals for Women's Health Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. AbbVie Company Details
Table 105. AbbVie Business Overview
Table 106. AbbVie Product
Table 107. AbbVie Revenue in Pharmaceuticals for Women's Health Business (2015-2020) (Million US$)
Table 108. AbbVie Recent Development
Table 109. Amgen Company Details
Table 110. Amgen Business Overview
Table 111. Amgen Product
Table 112. Amgen Revenue in Pharmaceuticals for Women's Health Business (2015-2020) (Million US$)
Table 113. Amgen Recent Development
Table 114. Johnson?Johnson Company Details
Table 115. Johnson?Johnson Business Overview
Table 116. Johnson?Johnson Product
Table 117. Johnson?Johnson Revenue in Pharmaceuticals for Women's Health Business (2015-2020) (Million US$)
Table 118. Johnson?Johnson Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pharmaceuticals for Women's Health Market Share by Type: 2020 VS 2026
Figure 2. Granules Features
Figure 3. Pills Features
Figure 4. Powder Features
Figure 5. Tincture Features
Figure 6. Tablets Features
Figure 7. Capsule Features
Figure 8. Other Features
Figure 9. Global Pharmaceuticals for Women's Health Market Share by Application: 2020 VS 2026
Figure 10. Postmenopausal Osteoporosis Case Studies
Figure 11. Endometriosis Case Studies
Figure 12. Polycystic Ovarian Syndrome Case Studies
Figure 13. Pregnancy Disorders Case Studies
Figure 14. Others Case Studies
Figure 15. Pharmaceuticals for Women's Health Report Years Considered
Figure 16. Global Pharmaceuticals for Women's Health Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Pharmaceuticals for Women's Health Market Share by Regions: 2020 VS 2026
Figure 18. Global Pharmaceuticals for Women's Health Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Pharmaceuticals for Women's Health Market Share by Players in 2019
Figure 21. Global Top Pharmaceuticals for Women's Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals for Women's Health as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Pharmaceuticals for Women's Health Revenue in 2019
Figure 23. North America Pharmaceuticals for Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Pharmaceuticals for Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Pharmaceuticals for Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Pharmaceuticals for Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Pharmaceuticals for Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Pharmaceuticals for Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Pharmaceuticals for Women's Health Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Allergan Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2015-2020)
Figure 32. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Lilly Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2015-2020)
Figure 36. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bayer Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2015-2020)
Figure 38. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. AbbVie Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2015-2020)
Figure 40. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Amgen Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2015-2020)
Figure 42. Johnson?Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Johnson?Johnson Revenue Growth Rate in Pharmaceuticals for Women's Health Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed